GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $11,452,000 | +6.9% | 263,090 | +7.0% | 0.11% | +20.0% |
Q1 2022 | $10,709,000 | -4.0% | 245,849 | -2.8% | 0.10% | +1.1% |
Q4 2021 | $11,151,000 | +11.8% | 252,849 | -3.1% | 0.09% | +3.3% |
Q3 2021 | $9,971,000 | -4.0% | 260,941 | 0.0% | 0.09% | -7.1% |
Q2 2021 | $10,391,000 | -32.1% | 260,941 | -39.1% | 0.10% | -35.1% |
Q1 2021 | $15,302,000 | -28.2% | 428,734 | -25.9% | 0.15% | -37.1% |
Q4 2020 | $21,303,000 | -34.6% | 578,882 | -33.1% | 0.24% | -49.3% |
Q3 2020 | $32,575,000 | -22.0% | 865,441 | -15.4% | 0.47% | -25.6% |
Q2 2020 | $41,747,000 | -5.6% | 1,023,455 | -12.4% | 0.64% | -18.0% |
Q1 2020 | $44,245,000 | -19.3% | 1,167,730 | +0.0% | 0.78% | +12.8% |
Q4 2019 | $54,857,000 | -10.3% | 1,167,412 | -18.5% | 0.69% | -15.5% |
Q3 2019 | $61,123,000 | +3.5% | 1,432,134 | -2.9% | 0.81% | +9.9% |
Q2 2019 | $59,043,000 | -14.9% | 1,475,330 | -11.2% | 0.74% | -14.0% |
Q1 2019 | $69,400,000 | +9.4% | 1,660,683 | 0.0% | 0.86% | -2.5% |
Q4 2018 | $63,455,000 | -7.4% | 1,660,683 | -2.6% | 0.88% | +16.6% |
Q3 2018 | $68,495,000 | -0.3% | 1,705,128 | 0.0% | 0.76% | -1.7% |
Q2 2018 | $68,734,000 | -0.7% | 1,705,128 | -3.7% | 0.77% | -2.4% |
Q1 2018 | $69,214,000 | +9.6% | 1,771,550 | -0.5% | 0.79% | +11.0% |
Q4 2017 | $63,124,000 | -7.7% | 1,779,641 | +5.6% | 0.71% | -10.3% |
Q3 2017 | $68,406,000 | -3.6% | 1,684,870 | +2.4% | 0.79% | -5.4% |
Q2 2017 | $70,982,000 | +2.3% | 1,646,146 | 0.0% | 0.84% | +2.8% |
Q1 2017 | $69,402,000 | +9.5% | 1,646,146 | 0.0% | 0.82% | +9.1% |
Q4 2016 | $63,393,000 | -8.6% | 1,646,146 | +2.4% | 0.75% | -10.8% |
Q3 2016 | $69,340,000 | -0.5% | 1,607,697 | 0.0% | 0.84% | -4.1% |
Q2 2016 | $69,678,000 | +8.6% | 1,607,697 | +1.6% | 0.88% | +13.2% |
Q1 2016 | $64,187,000 | +7.7% | 1,582,913 | +7.2% | 0.77% | +8.1% |
Q4 2015 | $59,596,000 | +6.3% | 1,476,976 | +1.3% | 0.72% | +2.4% |
Q3 2015 | $56,066,000 | +10.8% | 1,458,162 | +20.1% | 0.70% | +22.5% |
Q2 2015 | $50,581,000 | +4.9% | 1,214,427 | +16.2% | 0.57% | +5.6% |
Q1 2015 | $48,224,000 | +8.0% | 1,044,933 | +0.0% | 0.54% | +4.7% |
Q4 2014 | $44,660,000 | -3.4% | 1,044,923 | +3.9% | 0.52% | -13.6% |
Q3 2014 | $46,229,000 | -12.6% | 1,005,634 | +1.7% | 0.60% | -7.7% |
Q2 2014 | $52,880,000 | +49.5% | 988,772 | +49.3% | 0.65% | +49.8% |
Q1 2014 | $35,379,000 | +57.3% | 662,150 | +57.2% | 0.43% | +56.5% |
Q4 2013 | $22,488,000 | +228.8% | 421,201 | +208.9% | 0.28% | +176.0% |
Q3 2013 | $6,840,000 | +247.7% | 136,344 | +246.3% | 0.10% | +212.5% |
Q2 2013 | $1,967,000 | – | 39,366 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |